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Organ transplantation (liver and kidney) is a procedure 
that significantly improves the prognosis in patients with chro-
nic liver and kidney diseases, and clinical characteristics of or-
gan function that were in decline are normalized with a succe-
ssful organ replacement. A common complication of chronic 
liver disease is deterioration of nutritional status, whether it is 
primary or secondary malnutrition (Stickel et al., 2008; Cam-
pos et al., 2002).
Preoperative malnutrition, operative stress, postoperative 
protein catabolism, postintervention complications and the pe-
riod of fasting all have a significant influence on the success of 
transplantation (Stickel et al., 2008). Immediately after tran-
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splantation, the basic aim of nutrition is to ensure the appro-
priate diet, sufficient for recuperation and refill of the exhau-
sted nutrients’ supplies (Qiu et al., 2009). In addition, having 
in mind that ischemia-reperfusion injury is, at least partially, 
attributable to reactive oxygen species (ROS), supplements 
with antioxidative capacity are desirable (Codoñer-Franch 
et al., 2008). The appropriate enteral and parenteral nutrition 
have multiple positive effects on postoperative course of the 
patient’s recovery, such as shorter stay in the intensive care 
unit, and consequently lower medical expenses (Hasse et al., 
1995; Wicks et al., 1994). According to recommendations the 
early enteral nutrition begins within 24 hours after the tran-
splantation of liver or pancreas, if necessary even in combina-
tion with parenteral nutrition (Weimann et al., 2009).
Plank et al. (2005) concluded that in the patients at the ad-
vanced stage of liver disease, protein and energy malnutrition 
are very often a common condition. In patients with cirrhosis 
the increased ratio of proteins is catabolised and the protein 
deficiency is worsened with the deterioration of the disease. 
The care about a patient’s diet before and after the or-
gan transplantation is an important segment in the process of 
medical treatment. In spite of the knowledge that malnutriti-
on is a significant risk factor for a successful transplantation 
and postoperative recovery of the patient, there is still a large 
number of open questions about the selection of food and its 
application at the early postoperative phase. So far, the nutriti-
onal status of  patients and the risk of malnutrition were asse-
ssed on admittance, and followed up through the application of 
different questionarries. To the best of our knowledge, there is 
no data about the recorded nutritional intake during early po-
stoperative period for patients with liver or kidney transplant. 
Therefore, the aim of this investigation was to estimate total 
nutritional intake during the first two postoperative weeks 
in patients with liver or kidney transplant in order to assess 
whether minimal nutritional requirements are met. Some bio-
chemical parameters were analysed as possible biomarkers of 
nutritional recovery.
Subjects and Methods
The present study was a prospective cochort singlecenter 
trial that was conducted in Merkur University Hospital in Za-
greb, Croatia. Sixty-one adult (≥ 18 years) patients who were 
admitted for liver or kidney transplantation were included. Of 
the total number of patients, 48 received liver transplants, 11 
received kidney transplants and 2 patients received both, liver 
and kidney transplants. 
Among 48 liver transplant patients, 46 were diagnosed 
with cirrhosis, one patient suffered from Wilson’s disease, 
and one suffered trauma in car accident. In 19 patients cirr-
hosis developed as a consequence of the alcohol related liver 
disease (ARLD), while in others it was mainly the result of 
hepatitis B (HBV) or hepatitis C (HCV) virus infection. Besi-
des cirrhosis, 15 patients were diagnosed with hepatocellular 
carcinoma (mainly as a consequence of HBV and HCV infec-
tions).  Among 11 kidney transplant patients, 10 of them had 
diagnosys of renal failure (4 of them also had diabetes). One 
patient was diagnosed with necrosis of pancreas with hepatitis 
B and diabetes. Of the two patients with both liver and kidney 
transplants, one suffered from hepatocellular carcinoma, and 
the other from cirrhosis, both with kidney failure. Therefore 
these two patients were considered as liver transplants for stati-
stical analysis. Among the patients involved in this study, three 
died within 1 month, while the others were released home with 
precise recommendations about their diet.
This experiment was performed in accordance with the 
principles of the Declaration of Helsinki of the World Medi-
cal Association and was approved by the Ethics Committee of 
Merkur University Hospital, Zagreb, and School of Medicine, 
University of Zagreb, Croatia. At the beginning of the study all 
patients gave their written consent. 
Blood samples were collected before transplantation 
(day 0), and then on the 1st, the 3rd and the 7th day after the 
transplantation. Venous blood was collected under controlled 
pre-analytical conditions into vacutainer tubes (Becton Dic-
kinson, Franklin Lakes, NJ, USA) without additives. Serum 
was separated within 1 hour after blood collection by centri-
fugation at 1800×g for 10 min. All biochemical measurements 
were performed at the Department of Clinical Chemistry and 
Laboratory Medicine at the Department of Clinical Chemistry 
and Laboratory Medicine at the Merkur University Hospital, 
Zagreb, Croatia.  Catalytic concentrations of serum enzymes 
alanine aminotransferase (ALT; EC 2.6.1.2),  aspartate ami-
notransferase (AST; EC 2.6.1.1),  gamma-glutamyltransferase 
(GGT; EC 2.3.2.2) and  alkaline phosphatase (AP; EC 3.1.3.1) 
and concentrations of serum proteins, creatinine and urea, were 
determined by commercially available reagents (Olympus, Ire-
land). All measurements were performed on an Olympus AU 
600 analyzer (Olympus Mishima Co., Ltd., Shizuoka, Japan) 
according to instructions from the manufacturer. Urea to crea-
tinine molar ratio was calculated.
During their stay in the intensive care unit, the following 
formulas were used for the enteral and parenteral nutrition 
of patients: glucose solutions 5 and 10 % (Pliva Hrvatska 
plc, Zagreb, Croatia), glucose solution 40 %,  and Amino-
plasmal® Hepa-10 % (B. Braun Melsungen AG, Melsungen, 
Germany), albumin (human) 5 and 20 % (Institute of immu-
nology, Zagreb, Croatia), Nephrotect, Kabiven, Dipeptiven, 
Intralipid 10 % and Intralipid 20 % (Fresenius Kabi, Graz, 
Austria), OliChlinomel N7-1000E (Baxter, Lessines, Belgi-
um).
The Mini-nutritional assessment (MNA) test was applied 
to all participants by the same researcher. The version used in 
this study includes 6 items for dietetic assessment (concerning 
number of meals, food and fluid intakes, and autonomy of fee-
ding), with the maximal score of 14 points (Kondrup et al., 
2003; Kaiser et al., 2009). Screening score classifies patients 
in two categories: 1) ≥ 12 points - normal, not at risk; 2) ≤ 11 
points - possible malnutrition. 
The complete nutritional intake was monitored by a qua-
lified nutritionist during the patients’ stay in the intensive care 
unit and through first fourteen postoperative days. Total energy 
and nutrients intake was calculated based on the volume and 
composition of the applied solutions. After oral feeding was 
introduced, the type and the amount of consumed food was re-
corded and the nutritive composition calculated (Kaić-Rak and 
Antonić, 1990). For resting energy expenditure (REE) calcula-
tion the Harris-Benedict equation was used (Roza and Shizgal, 
1984). The estimation of protein requirements was based on 
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the recommended value of 1.2 g/kg body mass (Plauth et al., 
1997). 
Data were analyzed with statistical package Statistica 8.0 
(StatSoft Inc., Tulsa, USA). Depending on the results of distri-
bution normality testing, results are presented as mean ± SD, 
or as median and quartile range. Wilcoxon Matched Pairs Test 
was used to analyze differences between two variables, while 
Spearman’s correlation (r, P) was calculated for associations 
between parameters. P values ≤ 0.05 were considered statisti-
cally significant.
Results and discussion
General data on patients involved in the study, along with 
the body mass index (BMI), are given in Table 1. For pati-
ents with kidney transplant, the median value (24.4 kg/m2) for 
BMI was within the recommended values (18.5 - 24.9 kg/m2). 
However, in patients with liver transplant the increased ave-
rage BMI was detected (26.9 kg/m2). In the group with liver 
transplant 18 patients (36 %) were overweight, while in the 
group with kidney transplant 3 overweight patients (27.3 %) 
were identified. Only for 3 patients (6 %) from the liver group 
and for 3 patients (27.3 %) from the kidney group the calcula-
ted BMI was below 18.5 kg/m2.  
At the admission, the mean MNA score was 10.48 and 
9.27 points in liver and kidney transplant group, respectively. 








Age (years), mean (SD) 52.3 (11.3) 44.0 (12.4)







MNA score, mean (SD) 10.48 
(1.83)
9.27 (2.76)
at risk (MNA<11), n (%) 27 (54.0) 7 (63.6)
not at risk (MNA≥ 11), n (%) 23 (46.0) 4(36.4)
Body mass (kg), mean (SD) 79.1 (13.7) 66.8 (16.0)
Body mass index (kg/m²), 
mean (SD)
26.2 (3.9) 24.4 (6.0)
low (BMI < 18.5), n (%) 3 (6.0) 3 (27.3)
normal (18.5 ≤ BMI ≤ 24.9), 
n (%)
29 (58.0) 5 (45.5)
overweight (BMI ≥ 25), n 
(%)
18 (36.0) 3 (27.3)
Education, n (%)*
Elementary school (≤ 8 
years)
6 (19.3) 0 (0.0)
Secondary school (9 - 12 
years)
19 (61.4) 2 (33.3)
High school (> 12 years) 6 (19.3) 4 (66.7)
Smoking, n (%)*
no 25 (80.6) 5 (83.3)
≤ 10 cigarettes/day 3 (9.7) 1 (16.7)
> 10 cigarettes/day 3 (9.7) 0 (0.00)
MNA - Mini Nutritional Assessment
* The sum does not add up to total because of missing values
Metabolic status of the organ transplant recipients is cha-
racterized by a significant malnutrition. When evaluating the 
nutritive status of a patient, we often rely on the values of  body 
mass index (BMI), the recommended values of which are 20 
to 25 kg/m2. The mean BMI values for the patients involved 
in this study were within the recommended values or slightly 
increased, which can mislead to a conclusion that malnutrition 
is not present. However, severe liver damage resulted in prote-
in malnutrition, which is confirmed by the low serum protein 
levels (Table 1).
Care about the patient’s appropriate nutrition should start 
already during the treatment of the primary disease. At ad-
mittance, according to MNA, the increased risk of malnutrition 
was detected in 54 % of patients in the liver, and 63.6 % in the 
kidney transplant group. According to recently published data, 
malnutrition was found in 25 % to 54 % of hospitalized pati-
ents in the United States (Malone, 2015). Statistical data for the 
year 2012 revealed the prevalence of undernutrition in 10 % to 
70 % of Croatian patients, depending on diagnosis (Benković 
et al., 2014).
Nutrition of the patients involved in this study was 
followed in detail during their stay in the intensive care unit 
and the postoperative care, fourteen days in total. Diet included 
parenteral nutrition, ready-made formulas for enteral use and, 
when appropriate, oral feeding was introduced. The average 
daily energy intakes for patients with liver and kidney tran-
splant are given in Fig. 1. 
Figure 1.  The	average	daily	energy	intake	for	patients	with	
liver	and	kidney	transplant.
Carbohydrates remain the leading energy source during 
the follow-up period, with proteins introduced later, mainly 
through enteral protein-rich shakes. However, significantly 
low fat intake was noticed. Glucose represents a core nutri-
ent for all patients and its application begins already during 
the operative procedure. However, during the first three days 
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in more than 90 % of patients the total energy intake was be-
low REE as calculated by Harris-Benedict formula (Table 2). 
During the first week total energy intake was improved, but 
in approximately 50 % of the patients it was still below the 
requirements. 
During the first three days protein requirements were co-
vered in nearly 50 % of the patients, and during the first seven 
days the protein intake was satisfying in more than 70 % of 
patients (Table 2). 
Planning the appropriate diet after the organ transplanta-
tion represents a special challenge. There is increasingly more 
evidence of the advantages of enteral nutrition, compared to a 
total parenteral nutrition (TPN), although selection depends on 
the conditions of each individual patient. Research papers show 
that by using enteral nutrition the metabolic response to stre-
ss is improved, there are fewer technical and metabolic com-
plications, lower rate of infections, and improved synthesis in 
visceral muscles. Reduced expenses compared to TPN are not 
negligible (Bower  et al., 1986; Moore et al., 1992). However, 
a positive effect of TPN with the addition of somatostatin in the 
treatment of patients with ascites was observed (Baran et al., 
2008). Furthermore, a synthetic function, as well as the reduc-
tion of a damage to the liver transplant using alanyl-glutamine 
dipeptide in a TPN were reported (Qiu et al., 2009).
Table 2. The	average	energy	and	macronutrients	intake	during	the	first	three	and	seven	post-transplant	days
Organ Liver (n = 50) Kidney (n = 11) Liver (n = 50) Kidney (n = 11)
3 days average 7 days average
Protein intake (g/day), 
median (min-max)
88.75 (37.5 -156.7) 79.2 (16.7 – 130.0) 120.7 (85.7 – 184.9) 96.3 (66.5 – 137.1)
< Recommendation, n (%) 26 (52.0) 6 (54.5) 11 (22.0) 3 (27.3)
≥ Recommendation, n (%) 24 (48.0) 5 (45.5) 39 (78.0) 8 (72.7)
CHO intake (g/day),  
median (min-max)
118.3 (69.5 – 230.6) 132.0 (66.7 – 290.8)
207.2 (103.8 – 
557.3)
215.3 (94.2 – 290.3)
Fat intake (g/day),
median (min-max)
0.0 (0.0 – 51.3) 0.0 (0.0 – 37.44) 30.0 (0.0 – 91.0) 31.2 (0.0 – 59.3)
Energy intake (kJ/day), 
median (min-max)
3728 (2238 – 7966) 3326 (1393 – 7990) 6736 (3260 – 12200) 6464 (3100 – 7980)
< Recommendation, n (%) 47 (94.0) 10 (90.9) 25 (50) 5 (45.5)
≥ Recommendation, n (%) 3 (6.0) 1 (9.1) 25 (50) 6 (54.5)
Total serum proteins (g/L), 
mean (min-max)
49.9 (34.0 – 80.1) 44.2 (25.0 – 48.7) 48.4 (34.4 – 91.6) nd
CHO = carbohydrates
nd = not detected
Data for patients’ nutritional intake during the first two 
post-operative weeks are given in Fig. 2. 
Figure 2.  Average	daily	macronutrients	intake	for	patients	with	liver	(A)	and	kidney	(B)	transplant.
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Regarding the proteins intake, they are mostly introduced 
with formulas for enteral use, which is why their average intake 
during the first three days after the transplantation is rather low 
and covers the requirements in less than 50 % of the patients. 
After implementation of protein shakes the intake was impro-
ved, and after a week the average protein intake was sufficient 
in more than 70 % of patients (Fig. 2). Comparing the total 
protein intake and the concentration of proteins in blood of the 
patients we did not find any significant correlation. However, 
one should keep in mind that serum protein levels are affected 
by many variables, including inflammation, and do not corres-
pond proportionally to a nutritional intake (Banh, 2006). Since 
patients were followed up for fourteen days it can be assumed 
that further improvement will be reached with time.
In accordance with the statement that the diet of patients 
with a chronic liver disease must contain appropriate prote-
ins to avoid a severe protein deficiency (Sanchez and Aran-
da-Michel, 2006), branched chain amino acids which enable 
fast recovery of muscle tissue are frequently applied. However, 
Hansen et al. (2015) have recently shown that the diet with 
complex proteins stimulates proteolytic activity of enterocytes 
and results in improved growth.
It is important to point out that only one of our patients 
received the fat containing formula in the first three days, alt-
hough it is a well-known fact that fats contain twice the amou-
nt of energy per unit of mass compared to carbohydrates. The 
application of lipid formulas offers a possibility to ensure in a 
smaller volume the sufficient amount of energy that is so much 
needed for convalescens, as well as the essential fatty acids 
necessary for membrane structure and cell recovery (Delaš, 
2011).  The lack of long chain polyunsaturated fatty acids might 
be a contributing factor in chronic liver damage (Cabré  et al., 
1993; Cabre and Gassull, 1996), and the possibility to improve 
hepatic function and perhaps the outcome of liver transplanta-
tion by supplementation of arachidonic and/or docosahexae-
noic acid in cirrhotic patients was shown (Pazirandeh et al., 
2007). A direct protective effect of eicosapentaenoic acid on 
rat hepatocytes was refered (Shoma et al., 2007), which indi-
cates the possibility that the use of essential polyunsaturated 
fatty acids in the organ perfusion solution after the explantation 
might have a positive effect on the protective role, in order 
to reduce the damage, and preserve the function of the organ 
until the transplantation. In randomized, controlled clinical tri-
al with patients undergoing liver transplantation it was shown 
that n-3 polyunsaturated fatty acid-supplemented parenteral 
nutrition significantly reduces injury of the transplanted liver 
and improves postoperative recovery (Zhu et al., 2013). 
From the clinical laboratory results (Table 3), a severe 
organ damage in patients involved in the study can be seen, 
followed by a serious catabolism and loss of proteins. Enzymes 
alanine aminotranferase (ALT) and aspartate aminotransfera-
se (AST) are considered to be indicators of the liver activity, 
so the increase of catalytic concentration of these enzymes in 
the blood is an indicator of the liver damage, that can be of 
various etiologies. By catalyzing the transamination reacti-
on, which initiates the amino acid catabolism, these enzymes 
are involved directly in the decomposition of proteins. Their 
ratio in serum of healthy humans is about 1, with ALT only 
slightly higher. Since ALT is a cytosolic enzyme, and AST is, 
apart from cytosol, also present in mitochondria, the increased 
activity of these enzymes almost certainly indicates a severe 
liver disease such as cirrhosis. After transplantation, with the 
organ function reestablished, the level of these enzymes in blo-
od is reduced. In that process, a greater decrease in the value 
of mitochondrial enzyme, AST, is especially encouraging. In 
patients with  kidney transplants, the activity of ALT retained 
its tendency to increase, which is not surprising if it is kept in 
mind that in this case liver suffers only the secondary strain due 
to a kidney failure, and some time is needed for the kidney to 
take over its function.
After organ transplantation patients are at a high risk 
from the post-transplant acute renal failure. In the evaluation 
of kidney function, urea and creatinine levels in blood play a 
key role. Due to inability to eliminate metabolites and toxins, 
including urea and creatinine, through ineffective kidneys, 
these concentrations were almost five to ten times above refe-
rence intervals in patients waiting for kidney transplantation. 
After transplantation, creatinine concentration significantly 
decreased, indicating the recovery of kidney function. In pa-
tients with the liver disease, these changes are much less in-
tense. Urea to creatinine ratio can be useful in a differential 
diagnosis and is commonly used to distinguish between acute 
and chronic renal disease. However, changes in the ratio can 
also be caused by other disorders, including congestive he-
art failure, dehydration, severe catabolic state, severe liver 
dysfunction and malnutrition 
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AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP – alkaline phosphatase; GGT, gamma-glutamyl transferase; 
Δ - statistically significant difference compared to day 0; * - statistically significant difference liver vs. kidney
In our patients with kidney transplant the initial values of 
urea to cretinine ratio were lower compared to reference range 
(40 - 100:1 mol/mol). After three days the mean value reached 
lower limit indicating improvement in protein metabolism and 
kidney function. In patients with liver transplant, initial values 
were not significantly below the reference limit, but the obtai-
ned successive increase might also be a result of repaired pro-
tein metabolism. 
However, besides very well established correlations of 
biochemical parameters, i. e. AST to ALT, or urea to creatini-
ne, no significant correlations between biochemical parameters 
and nutritional intake were found.
The results of this preliminary study reassert the problem 
of (in)adequacy of perioperative nutrition in patients with li-
ver and/or kidney transplantation. By the analysis of total costs 
from disease-related undernutrition in Croatian patients, it was 
shown that only 7.1 % came from expenses for parenteral and 
enteral nutrition (Benković et al., 2014). In contrast to that, it 
was estimated that malnutrition increases total hospitalization 
costs for more than 20 % (Amaral et al., 2007).
Strengths of this study include its prospective design with 
detailed nutritional record, and focus on the patients with or-
gan transplantation. Limitations of the study include the lack 
of some important potential confounding information, such as 
medications and preoperative nutritional habits. More tran-
splantation centers should be included as well.
Further interventional studies are necessary, in order to 
provide the answer how to reduce the organ damage during 
explantation by changing the composition of perfusion soluti-
ons and how supplemental nutrition can accelerate the postope-
rative recovery. BMI and serum protein levels are not reliable 
indicators of malnutrition; therefore it is necessary to search 
for new protocols and additional methods with the aim to cle-
arly assess nutritional status. Urea to creatinine ratio might be 
of further interest in kidney transplant patients.
Conclusions
Severe damage to the liver and kidney inevitably causes 
increased catabolism and loss of body proteins. Organ tran-
splantation is a complex therapeutic procedure which enables 
better prospects of recovery from the illness, but its success 
and recovery of a patient largely depend on the appropriate 
diet. Special attention should be paid to the quantity and the 
quality of proteins. Insufficient application of lipid-containing 
formulas has been observed.
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